Vertex Pharmaceuticals, Inc. (VRTX)
446.00
+1.36
(+0.31%)
USD |
NASDAQ |
Dec 11, 16:00
447.67
+1.67
(+0.37%)
After-Hours: 17:24
Vertex Pharmaceuticals Cash from Investing (Quarterly): -117.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Amgen, Inc. | -414.00M |
| Eli Lilly & Co. | -2.983B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.241B |
| Cash from Financing (Quarterly) | -1.154B |
| Free Cash Flow | 3.337B |
| Free Cash Flow Per Share (Quarterly) | 4.424 |
| Free Cash Flow to Equity (Quarterly) | 832.20M |
| Free Cash Flow to Firm (Quarterly) | 1.142B |
| Free Cash Flow Yield | 2.89% |